KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Revenue (2018 - 2025)

Historic Revenue for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $103.7 million.

  • Twist Bioscience's Revenue rose 1689.15% to $103.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $391.6 million, marking a year-over-year increase of 1858.57%. This contributed to the annual value of $376.6 million for FY2025, which is 2032.05% up from last year.
  • Per Twist Bioscience's latest filing, its Revenue stood at $103.7 million for Q4 2025, which was up 1689.15% from $99.0 million recorded in Q3 2025.
  • Twist Bioscience's Revenue's 5-year high stood at $103.7 million during Q4 2025, with a 5-year trough of $31.2 million in Q1 2021.
  • Over the past 5 years, Twist Bioscience's median Revenue value was $65.3 million (recorded in 2023), while the average stood at $67.3 million.
  • Its Revenue has fluctuated over the past 5 years, first soared by 6512.47% in 2021, then surged by 1359.22% in 2023.
  • Twist Bioscience's Revenue (Quarter) stood at $42.0 million in 2021, then increased by 29.09% to $54.2 million in 2022, then soared by 31.81% to $71.5 million in 2023, then increased by 24.08% to $88.7 million in 2024, then rose by 16.89% to $103.7 million in 2025.
  • Its last three reported values are $103.7 million in Q4 2025, $99.0 million for Q3 2025, and $96.1 million during Q2 2025.